Pharmaceutical Compliance in Dubai Mainland: Complete Guide

Pharmaceutical work in Dubai mainland answers to two regulators at once, and confusing them is the most common cause of a stalled licence. Federal registration of a medicine and permission to import, manufacture or distribute it sit with the Ministry of Health and Prevention. The licence for the premises where the product is stored or dispensed, and for the pharmacist standing behind the counter, sits with the Dubai Health Authority. A company can hold one and be stopped by the other.

This guide sets out how the two layers divide, what has to be approved before a product can move, the ongoing obligations that follow registration, and what happens when an inspection produces a finding.

The Two Regulators, and What Each Controls

The Ministry of Health and Prevention operates at national level. It registers pharmaceutical products, licenses pharmaceutical companies, manufacturers, importers and distributors, issues import permissions for consignments, sets the registered price of medicines, and runs product recalls and safety communications.

The Dubai Health Authority operates at emirate level for Dubai mainland. It licenses health facilities — pharmacies, drug stores, warehouses, clinics — and the professionals working in them, and inspects those premises against its own standards.

Dubai Healthcare City is neither. It is a free zone with its own healthcare regulator and its own facility and professional licensing, and a licence issued there does not authorise activity in Dubai mainland. Groups that operate on both sides run two licensing files, not one, and should not assume an approval crosses over.

What Has to Be in Place Before Product Moves

Work through the approvals in sequence; each one gates the next.

• Company licence. A trade licence carrying the correct pharmaceutical activity in the authority's own wording, plus the federal licence for the company as an importer, distributor or manufacturer.
• Product registration. No unregistered medicine may be placed on the market. Registration covers the product, its dossier, its labelling and its pricing.
• Premises licence. The warehouse, drug store or pharmacy licensed by the health authority, with the storage conditions the product requires.
• Responsible pharmacist. A licensed professional in post. A facility without one is not compliant, whatever else is in order.
• Import permission for the consignment, obtained before shipment rather than after it lands.
• Additional control for narcotic and controlled or semi-controlled products, which carry separate permissions, separate storage requirements and separate record-keeping.

Cold chain is where consignments are actually lost. Temperature-controlled storage and transport have to be validated and monitored, and the records have to exist at the moment an inspector asks for them, not be reconstructible afterwards.

Obligations That Continue After Approval

Traceability. Medicines supplied in the UAE are tracked through the national track-and-trace system, and serialisation and reporting duties run down the supply chain from manufacturer to importer to distributor to pharmacy. Data quality failures here are treated as compliance failures, not as IT problems.

Safety reporting. Adverse events, quality defects and recalls must be reported to the regulator. A company needs a named person responsible for safety reporting, a written procedure and a log that shows what was reported and when. Recalls are executed on the regulator's terms, including how far down the chain the product must be retrieved and how the retrieval is evidenced.

Promotion. Promotional material for medicines requires approval, prescription medicines cannot be advertised to the public, and what may be offered to healthcare professionals is restricted. Marketing teams working to a head-office playbook written for another market are a recurring source of enforcement, so approve local materials locally.

Variations and renewals. A change to the manufacturing site, the formulation, the labelling or the licence holder is a regulatory event that has to be filed and approved. Selling under a changed specification before approval is treated as selling an unregistered product.

The Federal Laws Sitting on Top

Company structure is governed by the Commercial Companies Law, Federal Decree-Law No. 32 of 2021, which replaced Federal Law No. 2 of 2015. The requirement for 51% UAE-national ownership of mainland limited liability companies was removed by Federal Decree-Law No. 26 of 2020, so most mainland activities can be held in full foreign ownership, subject to the strategic-impact list and to any conditions the licensing authority applies to the specific activity. A branch of a foreign company is a different structure: not a separate legal person, with the parent carrying its liabilities, operating through a local service agent who takes no ownership of the business.

Distribution, supply and agency arrangements sit within the Commercial Transactions Law, Federal Decree-Law No. 50 of 2022, which replaced Federal Law No. 18 of 1993. Exclusivity, territory, termination rights and what happens to registered products if the relationship ends should all be settled in writing at the outset. A registration held in the name of a local partner is a well-known way to lose control of a product.

Employment is governed by Federal Decree-Law No. 33 of 2021, which replaced Federal Law No. 8 of 1980. Pharmacists and technicians need both a valid professional licence and a registered employment contract in one of the ministry's approved forms; a lapse in either is a facility problem, not just a personal one.

On tax, VAT applies at 5% under Federal Decree-Law No. 8 of 2017 as amended by Federal Decree-Law No. 18 of 2022, with the treatment of particular healthcare goods and services worth confirming for each product line. Corporate tax is imposed by Federal Decree-Law No. 47 of 2022 for financial years starting on or after 1 June 2023, at 0% on taxable income up to AED 375,000 and 9% above that.

Patient and Prescription Data

Pharmacies and distributors hold prescription records, insurance details and patient identifiers. Processing personal data is governed federally by Federal Decree-Law No. 45 of 2021, the Personal Data Protection Law, and health data carries additional restrictions on where it may be stored and when it may be sent outside the country. DIFC and ADGM apply their own data protection regimes to entities inside those centres.

Before signing a cloud contract or a group data-sharing arrangement, establish where patient and prescription records will physically sit, who may access them, and what approvals a cross-border transfer needs. Retrofitting this after a system is live is far more expensive than settling it in the procurement.

Inspections, Penalties and Disputes

Regulators inspect premises and records, and can warn, fine, suspend a product registration, suspend a facility licence, order a recall or close a site. The usual sequence gives the business a period to correct a deficiency before the sanction takes effect, so the highest-value response is a proper written answer to the first notice, with evidence, rather than waiting for escalation.

Between commercial parties — manufacturer, distributor, hospital group, insurer — risk can be allocated by contract, and the party best able to control a risk should carry it. Liability for gross negligence and wilful misconduct cannot be excluded by agreement, and a clause that tries will not hold. Product liability, recall cost allocation and indemnity wording deserve more attention than they usually get. Our work on medical dispute resolution typically starts from the regulatory file and the supply contract together, because the regulator's findings shape the commercial claim.

For advice on product registration, facility licensing, distribution agreements or responding to a regulatory notice, contact the Nour Attorneys team.

Schedule Your Consultation

Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice. Readers should seek professional legal advice tailored to their specific circumstances before making any decisions or taking any action based on the content of this article.

Nour Attorneys Team

Related Resources

Explore more of our insights on related topics:

• Healthcare Facility Licensing Requirements in the UAE
• Medical Malpractice Defence Strategies for Dubai Clinics
• Pharmaceutical Compliance Guidelines for UAE Distributors
• Patient Privacy Regulations for Multinational Entities